SCHEMBL900956

SCHEMBL900956

CC(O)[C@H](N)C(=O)NCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.58
ALDH1A1 P00352 2/20 0.56
CYP3A4 P08684 1/20 0.56
MME P08473 1/20 0.54
MEN1 O00255 2/20 0.53
MAPT P10636 1/20 0.53
SLC1A2 P43004 1/20 0.52
TARS1 P26639 1/20 0.50
MMP8 P22894 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL900959 1.00 KMT2A (0.58) KMT2AALDH1A1CYP3A4MMEMEN1
Trifluoroacetic Acid SCHEMBL14762492 0.91 ALDH1A1 (0.56) KMT2AALDH1A1CYP3A4MMEMEN1
SCHEMBL1790982 0.88 KMT2A (0.59) KMT2AALDH1A1CYP3A4MMEMEN1
SCHEMBL4743536 0.88 KMT2A (0.59) KMT2AALDH1A1CYP3A4MMEMEN1
SCHEMBL13592564 0.88 KMT2A (0.59) KMT2AALDH1A1CYP3A4MMEMEN1
Trifluoroacetic Acid SCHEMBL15284646 0.88 ALDH1A1 (0.49) KMT2AALDH1A1CYP3A4MMEMEN1
Trifluoroacetic Acid SCHEMBL15284644 0.88 ALDH1A1 (0.49) KMT2AALDH1A1CYP3A4MMEMEN1
SCHEMBL2236118 0.84 KMT2A (0.63) KMT2AALDH1A1CYP3A4MMEMEN1
SCHEMBL1790978 0.84 KMT2A (0.63) KMT2AALDH1A1CYP3A4MMEMEN1
SCHEMBL6461987 0.84 KMT2A (0.63) KMT2AALDH1A1CYP3A4MMEMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621508-B1 N-CARBOXYALKYL AURISTATINS AND THE USE THEREOF SEATTLE GENETICS INC (US) 2015-08-26 EP disclosed
EP-2621508-A1 N-CARBOXYALKYL AURISTATINS AND THE USE THEREOF Seattle Genetics, Inc. (US) 2013-08-07 EP disclosed
WO-2012041805-A1 N-CARBOXYALKYL AURISTATINS AND THE USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-04-05 WO disclosed